{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:15:18Z","timestamp":1792664118950,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"BMBF","doi-asserted-by":"publisher","award":["FKZ: 03IS2081"],"award-info":[{"award-number":["FKZ: 03IS2081"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jconrel.2015.06.035","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T05:33:11Z","timestamp":1436247191000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment"],"prefix":"10.1016","volume":"214","author":[{"given":"Karsten","family":"Voss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Falke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Bernsdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Grabow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Minrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Eickner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Peter","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Guthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Hovakimyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.06.035_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-013-1671-1","article-title":"Neuroprotection of medical IOP-lowering therapy","volume":"353","author":"Pfeiffer","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0010","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200522010-00001","article-title":"Management of glaucoma: focus on pharmacological therapy","volume":"22","author":"Marquis","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1389200033489488","article-title":"Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond","volume":"4","author":"Koevary","year":"2003","journal-title":"Curr. Drug Metab."},{"issue":"Pt 2","key":"10.1016\/j.jconrel.2015.06.035_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/eye.1998.56","article-title":"Compliance with timolol treatment in glaucoma","volume":"12","author":"Rotchford","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/PPA.S23780","article-title":"Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review","volume":"5","author":"Reardon","year":"2011","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0035","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","article-title":"The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity","volume":"118","author":"Sleath","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/02713683.2011.562340","article-title":"Ocular surface disease in patients with ocular hypertension and glaucoma","volume":"36","author":"Stewart","year":"2011","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-112-2-120","article-title":"Systemic effects of medications used to treat glaucoma","volume":"112","author":"Everitt","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0055","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/eye.2011.82","article-title":"Novel drug delivery systems for glaucoma","volume":"25","author":"Lavik","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0060","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2009.03.016","article-title":"Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response","volume":"137","author":"Anumolu","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0070","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biomaterials.2013.09.032","article-title":"In vivo performance of a drug-eluting contact lens to treat glaucoma for a month","volume":"35","author":"Ciolino","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0075","doi-asserted-by":"crossref","first-page":"895013","DOI":"10.1155\/2013\/895013","article-title":"Critical assessment of implantable drug delivery devices in glaucoma management","volume":"2013","author":"Manickavasagam","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2011.05.047","article-title":"In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment","volume":"415","author":"Natu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0085","first-page":"123","article-title":"Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye","volume":"7","author":"Natarajan","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0090","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2165\/00003495-199447030-00009","article-title":"Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing","volume":"47","author":"Goa","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jbm.b.31787","article-title":"Development of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid). II","volume":"97B","author":"Rohm","year":"2011","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2015.06.035_bb0100","first-page":"147","article-title":"Development of an injectable polymer-based local drug delivery system for subconjunctival treatment of glaucoma","volume":"58","author":"Sternberg","year":"2013","journal-title":"Biomed. Tech."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0105","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.biomaterials.2004.04.048","article-title":"The tissue response to an alkylene bis(dilactoyl)-methacrylate bone adhesive","volume":"26","author":"Heiss","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jbm.b.31654","article-title":"Development of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid). I","volume":"94","author":"Sternberg","year":"2010","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0115","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.biomaterials.2005.02.033","article-title":"Controlling cell adhesion and degradation of chitosan films by N-acetylation","volume":"26","author":"Freier","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.exer.2012.04.015","article-title":"Different fibroblast subpopulations of the eye: a therapeutic target to prevent postoperative fibrosis in glaucoma therapy","volume":"100","author":"Stahnke","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00061198-200412000-00005","article-title":"A pilot study of a system for grading of drainage blebs after glaucoma surgery","volume":"13","author":"Wells","year":"2004","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.prs.0000264398.85652.9a","article-title":"Clinical and morphological conditions in capsular contracture formed around silicone breast implants","volume":"120","author":"Prantl","year":"2007","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.exer.2005.10.011","article-title":"What controls aqueous humour outflow resistance?","volume":"82","author":"Johnson","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/pharmaceutics4010243","article-title":"Ophthalmic drug delivery in glaucoma\u2014a review","volume":"4","author":"Januleviciene","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pharmaceutics4010197","article-title":"Ocular drug delivery for glaucoma management","volume":"4","author":"Gooch","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/IJG.0b013e318237c6c4","article-title":"Patient acceptance and attitude toward an alternative method of subconjunctival injection for the medical treatment of glaucoma","volume":"22","author":"Chong","year":"2013","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0160","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0165","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exer.2013.04.007","article-title":"Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: in vitro and in vivo evaluation, preliminary results","volume":"112","author":"Giarmoukakis","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0175","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1016\/j.actbio.2014.05.031","article-title":"Sustained delivery of latanoprost by thermosensitive chitosan\u2013gelatin-based hydrogel for controlling ocular hypertension","volume":"10","author":"Cheng","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/02652040802095250","article-title":"Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)\/poly(lactic acid) microspheres for over 3months","volume":"26","author":"Bertram","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jconrel.2009.11.023","article-title":"Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function","volume":"142","author":"Hirakura","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0190","first-page":"74","article-title":"Role of biodegradable polymers in drug delivery","volume":"4","author":"Joshi","year":"2012","journal-title":"Int. J. Curr. Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000316696","article-title":"Drug-induced secondary cataract prevention: experimental ex vivo and in vivo results with disulfiram, methotrexate and actinomycin D","volume":"44","author":"Sternberg","year":"2010","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10856-012-4826-9","article-title":"In vitro degradation and drug release of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid) and chitosan","volume":"24","author":"Lurtz","year":"2013","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/jbm.a.30112","article-title":"Evaluation of in vivo biocompatibility and biodegradation of photocrosslinked hyaluronate hydrogels (HADgels)","volume":"70","author":"Miyamoto","year":"2004","journal-title":"J. Biomed. Mater. Res., Part A"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","article-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","volume":"73","author":"Huang","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.06.035_bb0215","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0039-6257(02)00302-8","article-title":"Ocular and systemic pharmacokinetics of latanoprost in humans","volume":"47","author":"Sj\u00f6quist","year":"2002","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0220","first-page":"5319","article-title":"In vitro hydrolysis of latanoprost by human ocular tissues","volume":"53","author":"Guerra","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0225","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/jop.2012.0190","article-title":"Safety assessment of subconjunctivally implanted devices containing latanoprost in Dutch-belted rabbits","volume":"29","author":"Jessen","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2015.06.035_bb0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol. J."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915300080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915300080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T02:31:33Z","timestamp":1691807493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915300080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":46,"alternative-id":["S0168365915300080"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.06.035","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}